Howard Berman - 03 Jan 2023 Form 4/A - Amendment Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
17 Jan 2023, 19:01:25 UTC
Date Of Original Report
04 Jan 2023
Previous filing
28 Dec 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding COYA Common Stock, par value $0.0001 per share 939,338 03 Jan 2023 By Bertex LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A amends the Form 4 filed by the Reporting Person on January 4, 2023 (the "Original Form 4"), which inadvertently reported the incorrect number of securities in column 5 of Table I. This Form 4/A is being filed solely to correct the number of securities reported in column 5 of Table I. No other amendments or changes have been made to the Original Form 4.
F2 Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.